How much is Cerebral Therapeutics worth in 2026?

Cerebral Therapeutics has a current valuation of N/A based on their Later Stage VC (Series C) round and secondary market data.

How much funding has Cerebral Therapeutics raised?

Cerebral Therapeutics has raised N/A in total funding across 1 funding rounds.

Cerebral Therapeutics

Drug Discovery

Cerebral Therapeutics valuation and funding history | Last updated: June 28, 2022 | 1 funding rounds

Current Valuation

N/A

As of June 28, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series C)

$40.0M

Last Funding

Jun 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
June 28, 2022	Later Stage VC (Series C)	$40.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Cerebral Therapeutics is currently valued at N/A as of June 28, 2022.

Track Cerebral Therapeutics Valuation Updates

Get notified when Cerebral Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Cerebral Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Cerebral Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Cerebral Therapeutics Worth in 2026?

Cerebral Therapeutics is a leading private company in the Drug Discovery sector. Track Cerebral Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Cerebral Therapeutics Valuation is Determined

Private company valuations like Cerebral Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.